Counterparts Clause Example from Business Contracts

This example Counterparts clause appears in 9 contracts from 6 companies

Counterparts. This Agreement may be executed in counterparts and each counterpart shall be deemed an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. The counterparts of this Agreement may be executed and delivered by facsimile, photo, email PDF, Docusign/Echosign or a similarly accredited secure signature service, or other electronic transmission or signature. ...This Agreement may be executed in one or more counterparts, and counterparts may be exchanged by electronic transmission (including by email), each of which will be deemed an original, but all of which together constitute one and the same instrument. View More
Found in InterDigital Inc. contract
InterDigital Inc. Contracts

Retirement & Transition Agreement and Release, dated December 9, 2019, by and between InterDigital and Jannie K. Lau (Filed With SEC on February 20, 2020)

Retirement & Transition Agreement and Release by and between Scott McQuilkin and InterDigital, Inc. dated April 2, 2018 (Filed With SEC on April 26, 2018)

Retirement & Transition Agreement and Release by and between Lawrence F. Shay and InterDigital, Inc. dated April 2, 2018 (Filed With SEC on April 26, 2018)

Arsanis, Inc. Contracts

Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020 (Filed With SEC on March 20, 2020)

Aravive, Inc. Contracts

Separation Agreement dated April 8, 2020 between the Company and Rekha Hemrajani (Filed With SEC on April 9, 2020)

Pulse Evolution Group, Inc. Contracts

Separation Agreement, by and among the Company and Jordan Fiksenbaum, dated as of March 18, 2021 (Filed With SEC on March 23, 2021)

SVMK Inc. Contracts

Transition Agreement and Release by and between Registrant and Thomas E. Hale, dated February 27, 2022 (Filed With SEC on May 5, 2022)

Outlook Therapeutics, Inc. Contracts

Separation Agreement and Release by and between the Registrant and Stephen J. McAndrew, Ph.D., effective as of November 26, 2018 (Filed With SEC on December 18, 2018)

Separation Agreement and Release by and between Oncobiologics, Inc. and Pankaj Mohan, Ph.D., dated July 2, 2018 (Filed With SEC on August 14, 2018)